Cosmo Pharmaceuticals N.V. (LON:0RGI)
London flag London · Delayed Price · Currency is GBP · Price in CHF
116.00
+0.60 (0.52%)
Feb 12, 2026, 5:04 PM GMT

Cosmo Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,7539017639008951,018
Market Cap Growth
89.31%18.10%-15.23%0.57%-12.08%16.39%
Enterprise Value
1,648795727864864956
Last Close Price
110.5454.2144.9550.9647.9063.34
PE Ratio
34.088.18-58.9149.16-
PS Ratio
11.224.089.489.9416.3718.64
PB Ratio
4.382.162.182.192.082.84
P/TBV Ratio
19.093.483.4314.099.522.87
P/FCF Ratio
30.186.9045.4135.34149.55128.14
P/OCF Ratio
27.826.7138.7230.5484.4887.48
EV/Sales Ratio
10.143.609.039.5415.8017.50
EV/EBITDA Ratio
22.785.9990.3823.6557.74176.12
EV/EBIT Ratio
26.906.46-34.7192.64590.89
EV/FCF Ratio
28.386.0943.2633.92144.35120.31
Debt / Equity Ratio
0.010.000.010.370.330.42
Debt / EBITDA Ratio
0.030.010.184.149.2024.49
Debt / FCF Ratio
0.040.010.106.0523.8518.97
Net Debt / Equity Ratio
-0.26-0.28-0.12-0.14-0.10-0.11
Net Debt / EBITDA Ratio
-1.54-0.88-5.23-1.64-2.94-7.38
Net Debt / FCF Ratio
-1.83-0.89-2.50-2.35-7.34-5.04
Asset Turnover
0.290.460.140.130.090.10
Inventory Turnover
3.643.273.063.293.504.66
Quick Ratio
3.593.393.221.4511.7711.06
Current Ratio
3.844.194.071.5712.9911.60
Return on Equity (ROE)
12.34%29.31%-2.47%3.58%4.75%-1.99%
Return on Assets (ROA)
6.88%15.87%-0.18%2.24%0.99%0.19%
Return on Invested Capital (ROIC)
16.65%35.94%-0.50%4.68%2.46%0.56%
Return on Capital Employed (ROCE)
12.20%24.90%-0.40%5.00%1.40%0.30%
Earnings Yield
2.93%12.23%-1.23%1.70%2.03%-0.70%
FCF Yield
3.31%14.49%2.20%2.83%0.67%0.78%
Dividend Yield
1.51%3.13%3.86%1.83%1.67%-
Payout Ratio
94.36%24.09%-90.61%--
Buyback Yield / Dilution
-1.65%-1.94%1.95%2.83%-16.81%1.11%
Total Shareholder Return
-0.14%1.19%5.81%4.66%-15.15%1.11%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.